24 August 2023: Clinical Research
Assessing the Impact of Hepatitis B Elimination Program on Maternal-Infant Health in West Java, Indonesia: A Cross-Sectional Study
Anita Deborah Anwar 1ABCDEFG , Annisa Dewi Nugrahani 1ABCDEF* , Dhanny Primantara Johari Santoso 1ABCDE , Muhammad Alamsyah Aziz 1ADEF , Lia Ulfah 2BCD , Asep Surachman 3BDOI: 10.12659/MSM.941639
Med Sci Monit 2023; 29:e941639
Table 5 Factors associated with infants’ HBsAg status.
| Variables | Total (n=59 for Mother; n=62 for Infants) | Infants’ HBsAg status | P value | Correlation (r) | OR | |
|---|---|---|---|---|---|---|
| HBsAg (+) | HbsAg (−) | |||||
| 1.000 | N/A | N/A | ||||
| Mean±SD | 59 | 28.00±1.00 | 30.23±6.48 | |||
| Median (range) | 28 (27–29) | 30 (20–42) | ||||
| 0.100 | 0.380 | 0.363 (0.002–0.815) | ||||
| Singleton | 56 | 1 | 55 | |||
| Multiple | 3 | 1 | 2 | |||
| 1.000 | 0.050 | N/A | ||||
| At term (≥37 weeks) | 54 | 2 | 52 | |||
| Preterm ( | 5 | 0 | 5 | |||
| 0.964 | 0.170 | N/A | ||||
| Spontaneous | 48 | 1 | 47 | |||
| Assisted vaginal delivery | 2 | 0 | 2 | |||
| Cesarean delivery | 9 | 1 | 8 | |||
| N/A | N/A | N/A | ||||
| Reactive | 59 | 2 | 57 | |||
| Non-reactive | 0 | 0 | 0 | |||
| 1.000 | 0.080 | N/A | ||||
| Reactive | 49 | 2 | 47 | |||
| Non-reactive | 10 | 0 | 10 | |||
| 0.144 | 0.064 | 0.500 (0.030–8.439) | ||||
| Yes | 39 | 1 | 38 | |||
| No | 20 | 1 | 19 | |||
| * | 0.106 | 0.326 (0.019–5.554) | ||||
| Yes | 44 | 1 | 43 | |||
| No | 24 | 1 | 14 | |||
| 1.000 | 0.043 | N/A | ||||
| Yes | 56 | 2 | 54 | |||
| No | 3 | 0 | 3 | |||
| * For numerical data, the value was tested with the unpaired test if the data were normally distributed, and with an alternative Mann-Whitney test if the data were not normally distributed. For categorical data, the value was calculated based on the chi-square test with an alternative Exact Fisher’s exact test if the conditions of the chi-square test were not met. For the delivery method group, analysis was conducted using the Kolmogorov-Smirnov test. A correlation test was conducted using the Cramer’s V test, except for the delivery method, which was conducted using the Contingency Coefficient test. Statistical significance was set at value HBIG – hepatitis B immune globulin; HBV vaccine – hepatitis B vaccine; HBsAg – hepatitis B surface antigen; OR – odds ratio. | ||||||